Publication | Closed Access
Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial
251
Citations
22
References
2013
Year
Ranibizumab Versus BevacizumabOcular DiseaseOphthalmologyAge-related DiseasesEye HealthGlaucomaRetinal TherapiesMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1